Cysteine deleted protegrin-1 (CDP-1): Anti-bacterial activity, outer-membrane disruption and selectivity

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 10, 2014, Pages 3006-3016

  Mohanram, Harini ^a   Bhattacharjya, Surajit ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Antibiotics; Antimicrobial peptides; Lipopolysaccharide; NMR; Protegrin 1

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL PEPTIDES; LIPOPOLYSACCHARIDE; NMR; PROTEGRIN-1;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; PROTEIN STRUCTURE, SECONDARY;

EID: 84905843048     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.06.018     Document Type: Article

References (64)

1. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395 (Pubitemid 34100944)
2. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3 2005 238 250 (Pubitemid 40298223)
3. E. Guani-Guerra, T. Santos-Mendoza, S.O. Lugo-Reyes, and L.M. Teran Antimicrobial peptides: general overview and clinical implications in human health and disease Clin. Immunol. 135 2010 1 11
4. P.C. Oyston, M.A. Fox, S.J. Richards, and G.C. Clark Novel peptide therapeutics for treatment of infections J. Med. Microbiol. 58 2009 977 987
5. C. Avitabile, F. Netti, G. Orefice, M. Palmieri, N. Nocerino, G. Malgieri, L.D. D'Andrea, R. Capparelli, R. Fattorusso, and A. Romanelli Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria Biochim. Biophys. Acta 1830 2013 3767 3775
6. J.L. Fox Antimicrobial peptides stage a comeback Nat. Biotechnol. 31 2013 379 382
7. G. Wang Database guided discovery of potent peptides to combat HIV-1 or superbugs Pharmaceuticals 6 2013 728 758
8. C.D. Fjell, J.A. Hiss, R.E. Hancock, and G. Schneider Designing antimicrobial peptides: form follows function Nat. Rev. Drug Discov. 11 2012 37 51
9. L.T. Nguyen, E.F. Haney, and H.J. Vogel The expanding scope of antimicrobial peptide structures and their modes of action Trends Biotechnol. 29 2011 464 472
10. Y. Shai Mode of action of membrane active antimicrobial peptides Biopolymers 66 2002 236 248 (Pubitemid 36098316)
11. W.C. Wimley Describing the mechanism of antimicrobial peptide action with the interfacial activity model ACS Chem. Biol. 5 2010 905 917
12. D.S. Snyder, and T.J. McIntosh The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics Biochemistry 39 2000 11777 11787
13. S. Bhattacharjya, and A. Ramamoorthy Multifunctional host defense peptides: functional and mechanistic insights from NMR structures of potent antimicrobial peptides FEBS J. 276 2009 6465 6473
14. L. Ding, L. Yang, T.M. Weiss, A.J. Waring, R.I. Lehrer, and H.W. Huang Interaction of antimicrobial peptides with lipopolysaccharides Biochemistry 42 2003 12251 12259 (Pubitemid 37296502)
15. N. Papo, and Y. Shai A molecular mechanism for lipopolysaccharide protection of gram-negative bacteria from antimicrobial peptides J. Biol. Chem. 280 2005 10378 10387 (Pubitemid 40395894)
16. Y. Rosenfeld, D. Barra, M. Simmaco, Y. Shai, and M.L. Mangoni A synergism between temporins toward gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer J. Biol. Chem. 281 2006 28565 28574 (Pubitemid 44506999)
17. R. Saravanan, M. Joshi, H. Mohanram, A. Bhunia, M.L. Mangoni, and S. Bhattacharjya NMR structure of temporin-1 Ta in lipopolysaccharide micelles: mechanistic insight into inactivation by outer membrane PLoS ONE 8 2013 e72718
18. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxin Annu. Rev. Biochem. 71 2002 635 700
19. J. Cohen The immunopathogenesis of sepsis Nature 420 2002 885 891 (Pubitemid 36019643)
20. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N. Engl. J. Med. 348 2003 1546 1554 (Pubitemid 36437931)
21. S. Bhattacharjya De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs Curr. Med. Chem. 17 2010 3080 3093
22. N.Y. Yount, and M.R. Yeaman Peptide antimicrobials: cell wall as a bacterial target Ann. N. Y. Acad. Sci. 1277 2013 127 138
23. M.G. Scott, A.C. Vreugdenhil, W.A. Buurman, R.E. Hancock, and M.R. Gold Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein J. Immunol. 164 2000 549 553 (Pubitemid 30043670)
24. T. Schuerholz, S. Domming, M. Hornef, A. Dupont, I. Kowalski, Y. Kaconis, L. Heinbockel, J. Andra, P. Garidel, T. Gutsmann, S. David, S. Sanchez-Gomez, G.M. Tejada, and K. Brandenburg Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects Curr. Drug Targets 13 2012 1121 1130
25. R. Dings, J.R. Haseman, D.B. Leslie, M. Luong, D.L. Dunn, and K.H. Mayo Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa Biochim. Biophys. Acta 1830 2013 3454 3457
26. A. Bhunia, R. Saravanan, H. Mohanram, M.L. Mangoni, and S. Bhattacharjya NMR structures and interactions of temporin-1Tl and temporin-1Tb with lipopolysaccharide micelles: mechanistic insights into outer membrane permeabilization and synergistic activity J. Biol. Chem. 286 2011 24394 24406
27. B. Japelj, P. Pristovsek, A. Majerle, and R. Jerala Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide J. Biol. Chem. 280 2005 16955 16961 (Pubitemid 41389156)
28. A. Bhunia, A. Ramamoorthy, and S. Bhattacharjya Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy Chemistry 15 2009 2036 2040
29. P.N. Domadia, A. Bhunia, A. Ramamoorthy, and S. Bhattacharjya Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization J. Am. Chem. Soc. 132 2010 18417 18428
30. S. Bhattacharjya, P. Domadia, A. Bhunia, S. Malladi, and S. David High resolution solution structure of a designed peptide bound to lipopolysaccharide: transferred nuclear Overhauser effects, micelle selectivity and anti-endotoxic activity Biochemistry 46 2007 5864 5874 (Pubitemid 46799149)
31. T. Kushibiki, M. Kamiya, T. Aizawa, Y. Kumaki, T. Kikukawa, M. Mizuguchi, M. Demura, S. Kawabata, and K. Kawano Interaction between tachyplesin I, an antimicrobial peptide derived from horseshoe crab, and lipopolysaccharide Biochim. Biophys. Acta 1844 2014 527 534
32. V.N. Kokryakov, S.S.L. Harwig, E.A. Panyutich, A.A. Shevchenko, G.M. Aleshina, O.V. Shamova, H.A. Korneva, and R.I. Lehrer Protegrins-leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins FEBS Lett. 327 1993 231 236 (Pubitemid 23211194)
33. J. Chen, T.J. Falla, H. Liu, M.A. Hurst, C.A. Fujii, D.A. Mosca, J.R. Embree, D.J. Loury, P.A. Radel, C. Chang, L. Gu, and J.C. Fiddes Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues Biopolymers 55 2000 88 98
34. H. Tamamura, T. Murakami, S. Horiuchi, K. Sugihara, A. Otaka, W. Takada, T. Ibuka, M. Waki, N. Yamamoto, and N. Fujii Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity Chem. Pharm. Bull. 43 1995 853 858
35. D. Gidalevitz, Y. Ishitsuka, A.S. Muresan, O. Konovalov, A.J. Waring, R.I. Lehrer, and K.Y. Lee Interaction of antimicrobial peptide protegrin with biomembranes Proc. Natl. Acad. Sci. U. S. A. 100 2003 6302 6307 (Pubitemid 36666576)
36. N. Ostberg, and Y. Kaznessis Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity Peptides 26 2005 197 206 (Pubitemid 40051415)
37. L.M. Gottler, R. Salud Bea, C.E. Shelburne, A. Ramamoorthy, and E.N. Marsh Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1 Biochemistry 47 2008 9243 9250
38. R.L. Fahrner, T. Dieckmann, S.S.L. Harwig, R.I. Lehrer, D. Eisenberg, and J. Feigon Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes Chem. Biol. 3 1996 543 550 (Pubitemid 26324167)
39. A. Aumelas, M. Mangoni, C. Roumestand, L. Chiche, E. Despaux, G. Grassy, B. Calas, and A. Chavanieu Synthesis and solution structure of the antimicrobial peptide protegrin-1 Eur. J. Biochem. 237 1996 575 583 (Pubitemid 26164589)
40. R. Mani, S.D. Cady, M. Tang, A.J. Waring, R.I. Lehrer, and M. Hong Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR Proc. Natl. Acad. Sci. U. S. A. 103 2006 16242 16247 (Pubitemid 44715181)
41. C. Roumestand, V. Louis, A. Aumelas, G. Grassy, B. Calas, and A. Chavanieu Oligomerization of protegrin-1 in the presence of DPC micelles. A proton high-resolution NMR study FEBS Lett. 421 1999 263 267 (Pubitemid 28045767)
42. A.A. Langham, A.S. Ahmad, and Y.N. Kaznessis On the nature of antimicrobial activity: a model for protegrin-1 pores J. Am. Chem. Soc. 130 2008 338 346
43. T. Lazaridis, Y. He, and L. Prieto Membrane interactions and pore formation by the antimicrobial peptide protegrin Biophys. J. 104 2013 633 642
44. S.S. Harwig, A. Waring, H.J. Yang, Y. Cho, L. Tan, and R.I. Lehrer Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations Eur. J. Biochem. 240 1996 352 357 (Pubitemid 26292741)
45. M.E. Mangoni, A. Aumelas, P. Charnet, C. Roumestand, L. Chiche, E. Despaux, G. Grassy, B. Calas, and A. Chavanieu Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation FEBS Lett. 383 1996 93 98
46. J.P. Tam, C. Wu, and J.L. Yang Membranolytic selectivity of cystine-stabilized cyclic protegrins Eur. J. Biochem. 267 2000 3289 3300 (Pubitemid 30341157)
47. J.R. Lai, B.R. Huck, B. Weisblum, and S.H. Gellman Design of non-cysteine-containing antimicrobial beta-hairpins: structure-activity relationship studies with linear protegrin-1 analogues Biochemistry 41 2002 12835 12842 (Pubitemid 35192512)
48. J.R. Lai, R.F. Epand, B. Weisblum, R.M. Epand, and S.H. Gellman Roles of salt and conformation in the biological and physicochemical behavior of protegrin-1 and designed analogues: correlation of antimicrobial, hemolytic, and lipid bilayer-perturbing activities Biochemistry 45 2006 15718 15730 (Pubitemid 46032492)
49. A. Ramamoorthy, S. Thennarasu, A. Tan, K. Gottipati, S. Sreekumar, D.L. Heyl, F.Y. An, and C.E. Shelburne Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding Biochemistry 45 2006 6529 6540 (Pubitemid 43787817)
50. R. Saravanan, H. Mohanram, M. Joshi, P.N. Domadia, J. Torres, C. Ruedl, and S. Bhattacharjya Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: mechanistic insights into outer-membrane permeabilization and endotoxin neutralization Biochim. Biophys. Acta 1818 2012 1613 1624
51. C.A. Aurell, and A.O. Wistrom Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS) Biochem. Biophys. Res. Commun. 253 1998 119 123 (Pubitemid 29015610)
52. L. Yu, M. Tan, B. Hob, J.L. Ding, and T. Wohland Determination of critical micelle concentrations and aggregation numbers by fluorescence correlation spectroscopy: aggregation of a lipopolysaccharide Anal. Chim. Acta. 556 2006 216 225 (Pubitemid 43042597)
53. P. Guntert Automated NMR protein structure calculation with CYANA Methods Mol. Biol. 278 2004 353 378
54. K. Wuthrich NMR of Proteins and Nucleic Acids 1986 John Wiley and Sons New York
55. Y. Rosenfeld, N. Papo, and Y. Shai Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides: peptide properties and plausible mode of action J. Biol. Chem. 281 2006 1636 1643
56. P.S. Tobias, K. Soldau, J.A. Gegner, D. Mintz, and R.J. Ulevitch Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD4 J. Biol. Chem. 270 1995 10482 10488
57. K. Nakanishi, N. Berove, and R.W. Woody Circular Dichroism: Principles and Applications 2000 John Wiley and Sons New York
58. S. Srimal, N. Surolia, S. Balasubramanian, and A. Surolia Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A Biochem. J. 315 1996 679 686
59. A. Bhunia, P.N. Domadia, and S. Bhattacharjya Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide Biochim. Biophys. Acta 1768 2007 3282 3291 (Pubitemid 350236077)
60. A. Bhunia, P. Domadia, J. Torres, K.J. Hallock, A. Ramamoorthy, and S. Bhattacharjya NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization J. Biol. Chem. 285 2010 3883 3895
61. A. Bhunia, H. Mohanram, P.N. Domadia, J. Torres, and S. Bhattacharjya Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide J. Biol. Chem. 284 2009 21991 22004
62. J. Howe, J. Andra, R. Conde, M. Iriarte, P. Garidel, M.H. Koch, T. Gutsmann, I. Moriyon, and K. Brandenburg Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B Biophys. J. 92 2007 2796 2805 (Pubitemid 46557854)
63. K. Brandenburg, A. David, J. Howe, M.H. Koch, J. Andra, and P. Garidel Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide Biophys. J. 88 2005 1845 1858 (Pubitemid 40976198)
64. L. Bellm, R.I. Lehrer, and T. Ganz Protegrins: new antibiotics of mammalian origin Expert Opin. Investig. Drugs 9 2000 1731 1742 (Pubitemid 30639324)